Ligand Pharmaceuticals Inc

13F Holdings History for Pelthos Therapeutics Inc. - Common Stock, par value $0.0001 per share (PTHS)

Symbol: PTHS on NYSE
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Ownership: 5.19M shares
Security Ownership: 49.9%

Ligand Pharmaceuticals Incorporated ownership in Pelthos Therapeutics Inc. Common Stock, par value $0.0001 per share (PTHS)

2025-11-10 - Ligand Pharmaceuticals Incorporated has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 5.19M shares of Pelthos Therapeutics Inc. Common Stock, par value $0.0001 per share (PTHS). This represents 49.9% percent ownership of the company. In their previous filing dated 2025-07-03, LIGAND PHARMACEUTICALS INC had reported owning 4.93M shares, indicating an increase of 5.3% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Ligand Pharmaceuticals Incorporated	49.9%		$175M	5.19M	+261,309	+5.3%	$33.80	13D/A	11/6/2025	10 Nov 2025 16:42:33
Ligand Pharmaceuticals Incorporated	49.9%			4.93M				13D	7/1/2025	3 Jul 2025 16:05:07